Kelly Michael Aaron

SEC source: 0001628280-26-041569 · wk-form4_1780949884.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2036-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

SEC source: 0001628280-26-040574 · wk-form4_1780530391.xml · derivative · entry 5

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,970

Underlying: Common Stock · 15,970 shares

Expires not disclosed

F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001628280-26-040574 · wk-form4_1780530391.xml · derivative · entry 4

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,069

Underlying: Common Stock · 11,069 shares

Expires 2036-06-01

SEC source: 0001628280-26-040574 · wk-form4_1780530391.xml · derivative · entry 3

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001628280-26-040574 · wk-form4_1780530391.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4.

SEC source: 0001769668-26-000002 · wk-form4_1778798752.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,590

F1 · shares: The award is subject to time-based vesting restrictions. The restrictions will lapse on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual stockholder meeting, so long as that meeting is at least 50 weeks after the prior annual meeting.

SEC source: 0001193125-26-182271 · ownership.xml · derivative · entry 6

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 74,872 shares

Expires 2035-06-05

F2 · kind: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F2 · price: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F4 · derivative.exercise_date: Each Option vested in full in connection with consummation of the Merger.

SEC source: 0001193125-26-182271 · ownership.xml · derivative · entry 5

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,467 shares

Expires 2034-06-06

F2 · kind: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F2 · price: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F3 · derivative.exercise_date: Each Option was fully vested.

SEC source: 0001193125-26-182271 · ownership.xml · derivative · entry 4

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,474 shares

Expires 2033-06-08

F2 · kind: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F2 · price: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F3 · derivative.exercise_date: Each Option was fully vested.

SEC source: 0001193125-26-182271 · ownership.xml · derivative · entry 3

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,423 shares

Expires 2032-06-09

F2 · kind: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F2 · price: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F3 · derivative.exercise_date: Each Option was fully vested.

SEC source: 0001193125-26-182271 · ownership.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,111 shares

Expires 2031-06-10

F2 · kind: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F2 · price: In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option.

F3 · derivative.exercise_date: Each Option was fully vested.

SEC source: 0001193125-26-182271 · ownership.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the "Merger"), which included 52,054 shares of Common Stock and 20,414 restricted stock units (which vested in full in connection with consummation of the Merger).

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 8

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-12

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 7

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,000 shares

Expires 2034-06-12

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 6

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,062

Underlying: Common Stock · 39,062 shares

Expires 2033-06-14

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 5

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,062 shares

Expires 2033-06-14

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 4

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,006

Underlying: Common Stock · 9,006 shares

Expires 2032-10-19

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 3

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,006 shares

Expires 2032-10-19

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,510

Underlying: Common Stock · 13,510 shares

Expires 2031-11-24

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001894562-25-000047 · wk-form4_1754440988.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,510 shares

Expires 2031-11-24

F1 · kind: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F1 · price: Effective as of August 1, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the "2019 Plan") and/or the 2022 Stock Option and Incentive Plan (the "2022 Plan" and, together with the 2019 Plan, the "Plans"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0000950170-25-083218 · ownership.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,872

Underlying: Common Stock · 74,872 shares

Expires 2035-06-05

F2 · derivative.exercise_date: One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.

SEC source: 0000950170-25-083218 · ownership.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,468

F1 · security: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

SEC source: 0001628280-25-029771 · wk-form4_1749161372.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2026 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

SEC source: 0001077183-25-000128 · wk-form4_1748981269.xml · derivative · entry 5

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,077

Underlying: Common Stock · 23,077 shares

Expires not disclosed

F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000128 · wk-form4_1748981269.xml · derivative · entry 4

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,107

Underlying: Common Stock · 16,107 shares

Expires 2035-06-01

SEC source: 0001077183-25-000128 · wk-form4_1748981269.xml · derivative · entry 3

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000128 · wk-form4_1748981269.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4.

SEC source: 0001077183-25-000112 · wk-form4_1748462854.xml · nonDerivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016

Disclosed balance after: 5,000

SEC source: 0000034067-25-000104 · wk-form4_1747343470.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,653

F1 · shares: The award is subject to time-based vesting restrictions. The restrictions will lapse on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual stockholder meeting, so long as the date of the next annual meeting is no earlier than April 29, 2026.

SEC source: 0000034067-25-000034 · wk-form4_1740694381.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,073

SEC source: 0001077183-24-000131 · wk-form4_1723581122.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,336 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000131 · wk-form4_1723581122.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,755

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4.

SEC source: 0001894562-24-000038 · wk-form4_1718398735.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 12, 2025 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date

SEC source: 0000950170-24-071005 · ownership.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,467

Underlying: Common Stock · 42,467 shares

Expires 2034-06-06

F2 · derivative.exercise_date: One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.

SEC source: 0000950170-24-071005 · ownership.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,054

F1 · security: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

SEC source: 0001077183-24-000094 · wk-form4_1717531749.xml · derivative · entry 8

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,254

Underlying: Common Stock · 12,254 shares

Expires not disclosed

F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-24-000094 · wk-form4_1717531749.xml · derivative · entry 7

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,672

Underlying: Common Stock · 8,672 shares

Expires 2034-06-01

SEC source: 0000034067-24-000085 · wk-form4_1715808281.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,555

F1 · shares: Represents shares of restricted stock that will vest on May 15, 2025.

SEC source: 0001077183-23-000120 · wk-form4_1692049223.xml · derivative · entry 6

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,336

Underlying: Common Stock · 11,336 shares

Expires not disclosed

F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-23-000120 · wk-form4_1692049223.xml · derivative · entry 5

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,353

Underlying: Common Stock · 8,353 shares

Expires 2033-08-10

SEC source: 0001894562-23-000024 · wf-form4_168695209562872.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,062

Underlying: Common Stock · 39,062 shares

Expires 2033-06-14

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

SEC source: 0001209191-23-036429 · doc4.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,474

Underlying: Common Stock · 30,474 shares

Expires 2033-06-08

F2 · derivative.exercise_date: One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.

SEC source: 0001209191-23-036429 · doc4.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,207

F1 · security: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

SEC source: 0000034067-23-000097 · wf-form4_168375270101739.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,035

F1 · shares: Represents shares of restricted stock that will vest on May 10, 2024.

SEC source: 0001628280-22-026822 · wf-form4_166638421646853.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,006

Underlying: Common Stock · 9,006 shares

Expires 2032-10-19

F1 · derivative.exercise_date: The shares underlying this option shall vest in three equal annual installments beginning on September 13, 2022, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001104659-22-076822 · tm2220275-5_4seq1.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-30

F1 · derivative.exercise_date: This option shall vest and become fully exercisable on June 30, 2023.

SEC source: 0001077183-22-000113 · wf-form4_165525379012128.xml · derivative · entry 4

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,882

Underlying: Common Stock · 13,882 shares

Expires 2029-06-10

SEC source: 0001077183-22-000113 · wf-form4_165525379012128.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,419

SEC source: 0001209191-22-035831 · doc4.xml · derivative · entry 2

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,423

Underlying: Common Stock · 45,423 shares

Expires 2032-06-09

F2 · derivative.exercise_date: One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.

SEC source: 0001209191-22-035831 · doc4.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,623

F1 · security: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.